SECURITY AGREEMENTSecurity Agreement • January 5th, 2011 • Clinical Data Inc • Pharmaceutical preparations • Delaware
This Security Agreement, dated as of December 29, 2010 (this “Security Agreement”), is made by Transgenomic, Inc., a Delaware corporation (the “Company”), in favor of PGxHealth, LLC, a Delaware limited liability company (together with its successors or assigns, “Secured Party”). Capitalized terms used and not otherwise defined herein are intended to have the meanings given to them in the Purchase Agreement (as defined below).
AMENDMENT TO ASSET PURCHASE AGREEMENTAsset Purchase Agreement • January 5th, 2011 • Clinical Data Inc • Pharmaceutical preparations • Delaware
This Amendment (the “Amendment”) to that certain Asset Purchase Agreement (the “Asset Purchase Agreement”), dated as of November 29, 2010, by and among PGxHealth, LLC, a Delaware limited liability company (“Seller”), Clinical Data, Inc., a Delaware corporation (“Seller Parent”), and Transgenomic, Inc., a Delaware corporation (“Buyer”) amends the Asset Purchase Agreement effective as of this 29th day of December, 2010, as follows:
NONCOMPETITION AND NONSOLICITATION AGREEMENTNoncompetition and Nonsolicitation Agreement • January 5th, 2011 • Clinical Data Inc • Pharmaceutical preparations • Delaware
This Noncompetition and Nonsolicitation Agreement (this “Agreement”) is made and entered into as of December 29, 2010 (the “Agreement Date”), by and among PGxHealth, LLC, a Delaware limited liability company (“Seller”), Clinical Data, Inc., a Delaware corporation (“Seller Parent”), and Transgenomic, Inc., a Delaware corporation (“Buyer”). Capitalized terms used and not otherwise defined in this Agreement shall have the meanings given to them in the Purchase Agreement (as defined below).
